• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于生理的药代动力学模型评估全身吸收的反卷积测量。

The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.

作者信息

Levitt David G

机构信息

Department of Physiology University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

BMC Clin Pharmacol. 2003 Mar 19;3:1. doi: 10.1186/1472-6904-3-1.

DOI:10.1186/1472-6904-3-1
PMID:12659643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC153531/
Abstract

BACKGROUND

An unknown input function can be determined by deconvolution using the systemic bolus input function (r) determined using an experimental input of duration ranging from a few seconds to many minutes. The quantitative relation between the duration of the input and the accuracy of r is unknown. Although a large number of deconvolution procedures have been described, these routines are not available in a convenient software package.

METHODS

Four deconvolution methods are implemented in a new, user-friendly software program (PKQuest, http://www.pkquest.com). Three of these methods are characterized by input parameters that are adjusted by the user to provide the "best" fit. A new approach is used to determine these parameters, based on the assumption that the input can be approximated by a gamma distribution. Deconvolution methodologies are evaluated using data generated from a physiologically based pharmacokinetic model (PBPK).

RESULTS AND CONCLUSIONS

The 11-compartment PBPK model is accurately described by either a 2 or 3-exponential function, depending on whether or not there is significant tissue binding. For an accurate estimate of r the first venous sample should be at or before the end of the constant infusion and a long (10 minute) constant infusion is preferable to a bolus injection. For noisy data, a gamma distribution deconvolution provides the best result if the input has the form of a gamma distribution. For other input functions, good results are obtained using deconvolution methods based on modeling the input with either a B-spline or uniform dense set of time points.

摘要

背景

未知输入函数可通过反卷积法来确定,该方法使用通过持续时间从几秒到几分钟不等的实验输入所确定的全身团注输入函数(r)。输入持续时间与r的准确性之间的定量关系尚不清楚。尽管已经描述了大量的反卷积程序,但这些程序并未包含在方便的软件包中。

方法

在一个全新的、用户友好的软件程序(PKQuest,http://www.pkquest.com)中实现了四种反卷积方法。其中三种方法的特点是输入参数可由用户进行调整以提供“最佳”拟合。基于输入可由伽马分布近似这一假设,采用一种新方法来确定这些参数。使用基于生理药代动力学模型(PBPK)生成的数据对反卷积方法进行评估。

结果与结论

根据是否存在显著的组织结合情况,11房室PBPK模型可由二指数函数或三指数函数准确描述。为了准确估计r,首次静脉采样应在恒速输注结束时或之前进行,且长时间(10分钟)恒速输注优于单次团注注射。对于有噪声的数据,如果输入具有伽马分布的形式,伽马分布反卷积可提供最佳结果。对于其他输入函数,使用基于用B样条或均匀密集时间点集对输入进行建模的反卷积方法可获得良好结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/6009de0f10e8/1472-6904-3-1-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/234c239254e2/1472-6904-3-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/33b032b26179/1472-6904-3-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/ddfc1ccc15c6/1472-6904-3-1-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/88abf6c36335/1472-6904-3-1-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/e1b7cfa6922f/1472-6904-3-1-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/2c3050108d43/1472-6904-3-1-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/1ea70eff3c2d/1472-6904-3-1-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/f8f975079009/1472-6904-3-1-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/1cff73506ca6/1472-6904-3-1-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/aa05e15b194e/1472-6904-3-1-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/38c9ddbacf5f/1472-6904-3-1-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/64274b19a8eb/1472-6904-3-1-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/20bd412e5b69/1472-6904-3-1-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/6e0daaa3ffa5/1472-6904-3-1-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/e0270305bab3/1472-6904-3-1-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/6009de0f10e8/1472-6904-3-1-16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/234c239254e2/1472-6904-3-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/33b032b26179/1472-6904-3-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/ddfc1ccc15c6/1472-6904-3-1-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/88abf6c36335/1472-6904-3-1-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/e1b7cfa6922f/1472-6904-3-1-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/2c3050108d43/1472-6904-3-1-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/1ea70eff3c2d/1472-6904-3-1-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/f8f975079009/1472-6904-3-1-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/1cff73506ca6/1472-6904-3-1-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/aa05e15b194e/1472-6904-3-1-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/38c9ddbacf5f/1472-6904-3-1-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/64274b19a8eb/1472-6904-3-1-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/20bd412e5b69/1472-6904-3-1-13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/6e0daaa3ffa5/1472-6904-3-1-14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/e0270305bab3/1472-6904-3-1-15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccd9/153531/6009de0f10e8/1472-6904-3-1-16.jpg

相似文献

1
The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption.使用基于生理的药代动力学模型评估全身吸收的反卷积测量。
BMC Clin Pharmacol. 2003 Mar 19;3:1. doi: 10.1186/1472-6904-3-1.
2
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.PKQuest:一种基于生理学的通用药代动力学模型。普萘洛尔的介绍与应用
BMC Clin Pharmacol. 2002 Aug 15;2:5. doi: 10.1186/1472-6904-2-5.
3
Human physiologically based pharmacokinetic model for propofol.丙泊酚的人体生理药代动力学模型。
BMC Anesthesiol. 2005 Apr 22;5(1):4. doi: 10.1186/1471-2253-5-4.
4
Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.基于生理的动脉-肘前静脉浓度差药代动力学建模
BMC Clin Pharmacol. 2004 Feb 19;4:2. doi: 10.1186/1472-6904-4-2.
5
Determination of drug absorption rate in time-variant disposition by direct deconvolution using beta clearance correction and end-constrained non-parametric regression.使用β清除率校正和末端约束非参数回归通过直接反卷积法测定时变处置中的药物吸收速率
Biopharm Drug Dispos. 2005 Nov;26(8):353-70. doi: 10.1002/bdd.468.
6
PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.PKQuest_Java:免费的交互式生理药代动力学软件包及教程。
BMC Res Notes. 2009 Aug 5;2:158. doi: 10.1186/1756-0500-2-158.
7
PKQuest: measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics.PKQuest:肠道吸收和首过代谢的测量——在人体乙醇药代动力学中的应用
BMC Clin Pharmacol. 2002 Aug 15;2:4. doi: 10.1186/1472-6904-2-4.
8
A computer program (DCN) for numerical convolution and deconvolution of pharmacokinetic functions.一个用于药代动力学函数数值卷积和去卷积的计算机程序(DCN)。
J Pharmacobiodyn. 1992 May;15(5):203-14. doi: 10.1248/bpb1978.15.203.
9
PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.制药研究和制造商协会(PHRMA)与美国疾病控制与预防中心(CPCDC)关于人体药代动力学预测模型的倡议,第5部分:使用基于生理学的药代动力学建模方法预测人体血浆浓度-时间曲线
J Pharm Sci. 2011 Oct;100(10):4127-57. doi: 10.1002/jps.22550. Epub 2011 May 3.
10
[Progress in methodology of establishing physiologically based pharmacokinetic models].[基于生理的药代动力学模型构建方法学进展]
Yao Xue Xue Bao. 2014 Jan;49(1):16-22.

引用本文的文献

1
PKQuest: PBPK modeling of highly lipid soluble and extracellular solutes.PKQuest:高脂溶性和细胞外溶质的生理药代动力学建模
ADMET DMPK. 2018 Nov 27;7(1):60-75. doi: 10.5599/admet.579. eCollection 2019.
2
Quantitation of small intestinal permeability during normal human drug absorption.正常人体药物吸收期间小肠通透性的定量研究。
BMC Pharmacol Toxicol. 2013 Jun 24;14:34. doi: 10.1186/2050-6511-14-34.
3
PKQuest_Java: free, interactive physiologically based pharmacokinetic software package and tutorial.PKQuest_Java:免费的交互式生理药代动力学软件包及教程。

本文引用的文献

1
PKQuest: capillary permeability limitation and plasma protein binding - application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics.PKQuest:毛细血管通透性限制与血浆蛋白结合——应用于人体菊粉、双氯西林和头孢曲松的药代动力学
BMC Clin Pharmacol. 2002 Sep 26;2:7. doi: 10.1186/1472-6904-2-7.
2
PKQuest: volatile solutes - application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics.PKQuest:挥发性溶质——在安氟醚、氧化亚氮、氟烷、甲氧氟烷和甲苯药代动力学中的应用
BMC Anesthesiol. 2002 Aug 15;2(1):5. doi: 10.1186/1471-2253-2-5.
3
PKQuest: measurement of intestinal absorption and first pass metabolism - application to human ethanol pharmacokinetics.
BMC Res Notes. 2009 Aug 5;2:158. doi: 10.1186/1756-0500-2-158.
4
An efficient deconvolution algorithm for estimating oxygen consumption during muscle activities.一种用于估计肌肉活动期间耗氧量的高效反卷积算法。
Comput Methods Programs Biomed. 2007 Mar;85(3):247-56. doi: 10.1016/j.cmpb.2006.12.008. Epub 2007 Jan 31.
5
Heterogeneity of human adipose blood flow.人体脂肪血流量的异质性。
BMC Clin Pharmacol. 2007 Jan 20;7:1. doi: 10.1186/1472-6904-7-1.
6
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.用于血管紧张素转换酶抑制剂的人体生理药代动力学模型:雷米普利和雷米普利拉。
BMC Clin Pharmacol. 2006 Jan 6;6:1. doi: 10.1186/1472-6904-6-1.
7
Human physiologically based pharmacokinetic model for propofol.丙泊酚的人体生理药代动力学模型。
BMC Anesthesiol. 2005 Apr 22;5(1):4. doi: 10.1186/1471-2253-5-4.
8
Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model.采用人肺再灌注模型监测两种不同丙酸倍氯米松气雾剂的初始肺部吸收情况。
Respir Res. 2005 Feb 24;6(1):21. doi: 10.1186/1465-9921-6-21.
9
Physiologically based pharmacokinetic modeling of arterial - antecubital vein concentration difference.基于生理的动脉-肘前静脉浓度差药代动力学建模
BMC Clin Pharmacol. 2004 Feb 19;4:2. doi: 10.1186/1472-6904-4-2.
10
The pharmacokinetics of the interstitial space in humans.人体间质间隙的药代动力学。
BMC Clin Pharmacol. 2003 Jul 30;3:3. doi: 10.1186/1472-6904-3-3.
PKQuest:肠道吸收和首过代谢的测量——在人体乙醇药代动力学中的应用
BMC Clin Pharmacol. 2002 Aug 15;2:4. doi: 10.1186/1472-6904-2-4.
4
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.PKQuest:一种基于生理学的通用药代动力学模型。普萘洛尔的介绍与应用
BMC Clin Pharmacol. 2002 Aug 15;2:5. doi: 10.1186/1472-6904-2-5.
5
A fast annealing evolutionary algorithm for global optimization.一种用于全局优化的快速退火进化算法。
J Comput Chem. 2002 Mar;23(4):427-35. doi: 10.1002/jcc.10029.
6
Intestinal absorption and presystemic elimination of the prokinetic agent, EM574, in the rabbit.促动力剂EM574在兔体内的肠道吸收及首过消除
J Pharm Sci. 2002 Jan;91(1):217-28. doi: 10.1002/jps.10002.
7
WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems.WINSTODEC:一种用于生理和药代动力学系统的随机反卷积交互式程序。
Comput Methods Programs Biomed. 2002 Jan;67(1):67-77. doi: 10.1016/s0169-2607(00)00151-6.
8
An extended point-area deconvolution approach for assessing drug input rates.一种用于评估药物输入速率的扩展点面积去卷积方法。
Pharm Res. 2001 Oct;18(10):1426-34. doi: 10.1023/a:1012252822432.
9
Application of a gamma model of absorption to oral cyclosporin.γ吸收模型在口服环孢素中的应用。
Clin Pharmacokinet. 2001;40(5):375-82. doi: 10.2165/00003088-200140050-00004.
10
Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.健康志愿者通过都保、准纳器和定量吸入器吸入丙酸氟替卡松后的吸收动力学。
Clin Pharmacokinet. 2000;39 Suppl 1:1-8. doi: 10.2165/00003088-200039001-00001.